Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication

NCT00725881 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: Trans sodium crocetinate (TSC)
DRUG: 0.9% normal saline

Sponsor

Diffusion Pharmaceuticals Inc